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Abstract  
 
Aim/hypothesis: Obesity is associated with increased triacylglycerol (TAG) storage in 
adipose tissue and insulin resistance. The mobilization of stored TAG is mediated by 
HSL and the recently discovered ATGL. The aim of the present study was to examine 5 
whether ATGL and HSL mRNA and protein expression are altered in insulin resistant 
conditions. In addition, we investigated whether a possible impaired expression could 
be reversed by a period of weight reduction.  
Methods: Adipose tissue biopsies were taken from obese subjects (n=44) with a wide 
range of insulin resistance, before and just after a 10-week hypocaloric diet. ATGL 10 
and HSL protein, and mRNA expression was determined by Western blot and RT-
qPCR, respectively. Results: Fasting insulin levels and the degree of insulin resistance 
(HOMAir) were negatively correlated with ATGL and HSL protein expression; 
independent of age, gender, fat cell size and body composition. Both mRNA and 
protein levels of ATGL and HSL were reduced in insulin resistant compared to 15 
insulin sensitive subjects (P<0.05). Weight reduction significantly decreased ATGL 
and HSL mRNA and protein expression. A positive correlation between the decrease 
in leptin and the decrease in ATGL protein level after weight reduction was observed.  
Finally, ATGL and HSL mRNA and protein levels seem to be highly correlated, 
indicating a tight coregulation and transcriptional control.  20 
Conclusions: In obese subjects insulin resistance and hyperinsulinemia are strongly 
associated with ATGL and HSL mRNA and protein expression independent of fat 
mass. Data on weight reduction indicated that also other factors (e.g. leptin) relate to 
ATGL and HSL protein expression. 
 25 
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Introduction 
 
Obesity is characterized by increased triacylglycerol (TAG) storage in adipose tissue 
and insulin resistance. The mobilization of stored TAG (lipolysis) is mediated by 
hormone-sensitive lipase (HSL). For more than 30 years, the paradigm has been that 5 
HSL is the rate-limiting enzyme responsible for TAG breakdown. Studies in HSL 
knockout mice (1-6) raised doubt on the rate-limiting role of HSL in TAG metabolism 
and suggested that at least one additional lipase in adipose tissue should be active that 
preferentially hydrolyzes the first ester bond of the TAG molecule. Recently, a new 
TAG lipase that belongs to a gene family characterized by the presence of a patatin-10 
domain was identified (7-9). Zimmermann et al. termed this new non-HSL lipase: 
adipose triglyceride lipase (ATGL), being predominantly expressed in adipose tissue 
(9). 
An impaired catecholamine-induced lipolysis and a reduced HSL expression in 
preadipocytes and differentiated adipocytes is observed in obesity (10-12). This 15 
blunted catecholamine-induced lipolysis has been proposed to be a cause of excessive 
accumulation of body fat. Indeed, studies in first-degree relatives of obese subjects 
demonstrate an impaired catecholamine-mediated lipolysis (13). Furthermore, the 
impaired catecholamine-induced lipolysis did not improve after weight loss, 
indicating that it may be an early factor in the development or maintenance of 20 
increased fat stores (14-17). A plausible other interpretation is that this reduced 
lipolytic response is an appropriate downregulation of lipolysis per unit fat mass to 
prevent an excessive fatty acid outflow from the expanded fat mass and to prevent 
worsening of the insulin resistant state. In line, fasting insulin concentrations have 
been shown to be inversely related to fatty acid efflux from adipose tissue (18). 25 
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Moreover, insulin downregulates ATGL and HSL mRNA expression in 3T3-L1 
adipocytes and HSL mRNA expression is increased in adipocytes from insulin-
deficient animals (19-22). In addition, ATGL is downregulated in animal models for 
insulin resistance (ob/ob and db/db) and HSL knockout animals show signs of 
impaired insulin sensitivity in adipose tissue and skeletal muscle (4, 7). Thus, there 5 
seems to be a negative relationship between insulin, ATGL and HSL expression.  
The aim of the present study was to investigate whether the degree of insulin 
resistance and hyperinsulinemia are, independently of fat mass, related to an impaired 
ATGL and HSL protein expression in a group of overweight-obese subjects with a 
wide range of insulin resistance, selected from an existing cohort. In addition, we 10 
investigated the impact of weight loss by means of a hypocaloric diet (low-fat vs. 
medium-fat diet) on adipose tissue ATGL and HSL protein levels. To the best of our 
knowledge this is the first time that ATGL protein levels are measured in human 
adipose tissue.  
 15 
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Material and Methods 
 
Subjects  
This study is part of the European multicentre study NUGENOB (NUtrient-GENe 
Interactions in human OBesity), which is described in detail elsewhere (23-25). Only 5 
the overweight-obese subjects from the Maastricht centre participated in this part of 
the study. The basic selection criteria for overweight-obese subjects were age 20-50y 
and BMI≥26kg/m2. Exclusion criteria were: weight change > 3kg within the 3 months 
prior to the study start; drug treated hypertension, diabetes or hyperlipidemia; thyroid 
disease; surgically treated obesity; pregnancy, alcohol or drug abuse and participation 10 
in other simultaneous ongoing trials. All subjects were recruited by means of an 
advertisement in a local newspaper, informed in detail about the investigation and 
their consent was obtained before participating in the study. From the 116 participants 
at the Maastricht centre, a selection of 22 insulin sensitive (IS) and 22 insulin resistant 
(IR) subjects was made. Insulin sensitivity was assessed by the HOMA (homeostasis 15 
model assessment) index for insulin resistance (HOMAir) calculated from fasting 
glucose and insulin according to the equation of Matthews (26). The median for 
HOMAir in the total Maastricht cohort was 2.19 (range: 0.4 - 9.9). Subjects above the 
50th percentile of HOMAir were assigned as IR and subjects below the 50th percentile 
as IS. Before entering the study, all subjects were in good health as assessed by 20 
medical history and physical examination. The Medical Ethical Review Committee of 
Maastricht University approved the study protocol and the clinical investigations were 
performed according to the Declaration of Helsinki. 
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Study design 
A clinical investigation day took place before and just after a 10-week dietary 
intervention with either low-fat or medium-fat diets (see dietary intervention).  
Subjects arrived at the clinical research centre at 8:00 a.m. after a 12 hours overnight 
fast and a 3-day run in period, in which they had to avoid excessive physical activity 5 
and alcohol consumption, described previously in detail (23). During this day the 
subjects underwent anthropometric measurements (see below) and an adipose tissue 
biopsy was taken (see adipose tissue biopsy). In addition, a venous basal blood 
sample was drawn for further analysis (see biochemical analysis).  
 10 
Dietary intervention 
Subjects followed one of two energy-restricted diets: a medium-fat (n=23) or a low-
fat (n=21) diet. Data on the different diets and how the diet was controlled are 
published elsewhere (23). The target macronutrient composition of the two diets was 
as follows: low-fat diet, 20–25% of total energy was provided by fat; the 15 
corresponding figure for the medium-fat diet was 40–45%. Both diets derived 15% of 
total energy from protein and the remainder (60–65% and 40–45% for the low-fat and 
medium-fat diets, respectively) from carbohydrates. Both diets were designed to 
provide 600 kcal/day less than the individual estimated energy expenditure based on 
resting metabolic rate, measured using a ventilated hood system, expressed in 20 
kcal/day and multiplied by 1.3. 
 
Anthropometric measurements 
After subjects voided their bladder body weight was determined on a calibrated 
electronic scale, accurate to 0.1 kg. Waist and hip circumference measurements to the 25 
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nearest 1 cm were made midway between the lower rib and iliac crest with the 
participant standing upright. Height was measured using a wall-mounted stadiometer. 
BMI was calculated as body weight in kilograms divided by squared height in meters. 
Fat mass (FM) and fat free mass (FFM) were assessed using multifrequency 
bioimpedance (QuadScan 4000; Bodystat, Douglas, Isle of Man, British Isles). The 5 
percentage body fat (%BF) was calculated from total fat mass (kg) and body weight. 
 
Adipose tissue biopsy 
A subcutaneous adipose tissue biopsy was taken from the abdominal region early in 
the morning after an overnight fast. The second biopsy was taken in week 10 of the 10 
dietary intervention. Biopsies were performed under local anesthesia (Xylocaine  
0,5%,  Lidocaine 0,5%; AstraZeneca BV, Zoetermeer, The Netherlands) on the left or 
right side of the abdomen about 5 cm lateral from the umbilicus using a Hepafix-
luerlock syringe (Braun Medical) and a 146x3 1/5” (2,10x80 mm) Braun-Sterican 
needle. The biopsy was washed in physiological saline and stored in a sterile 15 
polypropylene tube at -80°C until further analysis. 
 
Biochemical analysis 
Plasma glucose concentrations (ABX Diagnostics, Montpellier, France) were 
measured on a COBAS MIRA automated spectrophotometer (Roche Diagnostica, 20 
Basal, Switzerland). Triacylglycerol (TAG) (Sigma, St Louis, USA), free fatty acids 
(FFA) (NEFA C kit, Wako Chemicals, Neuss, Germany) and glycerol (Boehringer 
Mannheim, Germany) were measured on a COBAS FARA centrifugal 
spectrophotometer (Roche Diagnostica, Basal, Switzerland). Standard samples with 
known concentrations were included in each run for quality control. Plasma insulin 25 
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and serum leptin were measured with a double antibody radioimmunoassay (Insulin 
RIA 100, Kabi-Pharmacia, Uppsala, Sweden; Human leptin RIA kit, Linco research, 
Inc, St.Charles, Missouri, USA).  
 
Fat cell volume (FCV) and fat cell weight (FCW) 5 
Fat cell characteristics were determined in a subset of the same cohort (n=39; 
19IS/20IR; HOMAir: 1.4±0.1 vs. 4.7±0.5, P<0.01). Weight loss after diet was the 
same among these subjects as in the whole cohort (data not shown). Also, with respect 
to other metabolic parameters this subgroup was comparable to the group in which 
ATGL and HSL protein and mRNA expression was determined (see under results). 10 
Adipose tissue was subjected to collagenase treatment, and the mean volume and 
weight of the isolated fat cells were determined as previously described (27).  
 
Sample preparation 
About 200 mg adipose tissue was ground to a fine powder under liquid nitrogen and 15 
homogenized in 200 µl of ice-cold buffer: 8M urea, 2% 3-[(3-
cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS, Sigma C9426), 
65 mM dithiotreitol (DTT, Bio-Rad 161-0611), protease inhibitor (Sigma P8340) and 
phosphatase inhibitor cocktail (Sigma P5726). The homogenate was vortexed for 5 
min and centrifuged at 20000 × g for 30 minutes at 4°C. The supernatant was 20 
carefully collected and aliquots were stored at -80°C. The protein concentration was 
determined by Bradford based protein assay (Bio-Rad 500-0006). 
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Western blot analysis 
Ten µg of protein were separated using 10% SDS-PAGE and then transferred to a 
nitocellulose membrane. An affinity purified polyclonal antibody was raised in rabbit 
against a 15 amino-acid peptide (amino-acids 386-400, GRHLPSRLPEQVERL) of 
human ATGL (Eurogentec, Seraing, Belgium). In Western blot analysis a single band 5 
at 56kDa was detected which disappeared after preincubation of the antibody with the 
peptide. This band corresponds to the predicted molecular mass of the human ATGL 
protein (9). In addition, when COS cells were transfected with cDNA coding for 
human ATGL, also a single band of 56kDa was observed following western blot of 
extracted cellular protein. HSL was detected using a rabbit polyclonal antibody, raised 10 
and purified against recombinant human HSL. The HSL antibody has been previously 
validated (28). The secondary antibody was a horseradish peroxidase-conjugated anti-
rabbit immunoglobin (DAKO, Glostrup, Denmark). Antigen–antibody complexes 
were visualized using enhanced chemiluminescence (ECL+, Amersham Biosciences, 
UK) and a Kodak Image Station (Kodak, Glostrup, Denmark). Quantification of 15 
antigen–antibody complexes was performed using Quantity One® 1-D analysis 
software (Bio-Rad).  Optical density units are expressed as adjusted volume (Adj. 
Vol. OD, sum of pixels inside the volume boundary x area of a single pixel (in mm2) 
minus the background volume). Differences in loading were adjusted to β-actin 
protein levels and an isolated mature adipocyte lysate was included as positive 20 
control.  
 
Adipose tissue mRNA analysis  
ATGL and HSL mRNA expression was determined in a subset of adipose tissue 
samples of 26 subjects (13IS/13IR; 14F/12M) before and after the diet. Total RNA was 25 
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extracted from adipose tissue using the RNeasy mini kit (Qiagen, Hilden, Germany). 
The RNA concentration and purity were assessed spectrophotometrically. An Agilent 
2100 bioanalyser (Agilent Technologies, Massy, France) was used to confirm the 
integrity of the RNA. From each sample, 1 µg of total RNA was reverse-transcribed to 
cDNA using Superscript II Revserse Transcriptase (InVitroGen, Cergy Pontoise, 5 
France) and random hexamer primers (Invitrogen). HSL and ATGL mRNAs were 
quantified using pre-made gene expression assays (Applied Biosystems). 18S 
ribosomal RNA was used as control to normalize gene expression.  
 
Statistics 10 
All variables were checked for normal distribution and variables with a skewed 
distribution were ln-transformed to satisfy conditions of normality.  
First, univariate regression analysis was performed to identify variables that 
contribute to ATGL and HSL protein expression and to changes in protein expression 
induced by weight loss. Subsequently, a multivariate regression analyses was 15 
performed with ATGL or HSL protein levels as dependent variables and age, gender, 
FM, FFM, waist circumference, circulating insulin and leptin levels as independent 
variables (model 1). The same model was repeated with HOMAir as independent 
instead of insulin (model 2). To study the impact of weight reduction, changes in 
ATGL or HSL protein level were entered as dependent variable in the multivariate 20 
regression model with age, gender, change in fat mass, fat free mass, circulating 
insulin and leptin as independents. ATGL and HSL mRNA and protein levels were 
compared between insulin sensitive (IS) and insulin resistant (IR) subjects using 
Student’s unpaired t-test. Antropometric and metabolic parameters, HSL and ATGL 
mRNA and protein levels were compared before and after the diets using Student’s 25 
paired t-test. The differential effect of the diets was assessed with analysis of 
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covariance using diet as fixed factor. To avoid multicollinearity in the regression 
model independent variables with a correlation >0.8 were not simultaneously included 
in the model. The impact of the independent variables is described as unstandardized 
beta or regression coefficients. A P-value less then or equal to 0.05 was considered 
statistically significant. All analyses were performed using SPSS for Mac Os X 5 
version 11.0 (SPSS, Chicago, IL, USA). 
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Results 
 
Characteristics of the study subjects 
Anthropometric and metabolic characteristics of the study subjects before and after a 
10-week hypocaloric diet are displayed in table 1. Extensive data on the effects of the 5 
hypocaloric diet in the total NUGENOB cohort were reported previously (23). The 
diet resulted in significant loss of body weight (before vs. after: 98.7±3.2 vs. 90.0±3.3 
kg, P<0.001), fat mass (37.4±1.6 vs. 30.7±1.5 kg, P<0.001) and a significantly 
decreased BMI (34.1±0.7 vs. 31.3±0.7 kg/m2, P<0.001). In addition circulating fatty 
acids (506±24 vs. 418±22 µM.L-1, P=0.016), glycerol (105±11 vs. 83±8 µM.L-1, 10 
P=0.003) and leptin (24.7±2.3 vs. 14.5±1.5 ng/ml, P<0.001) decreased. There were no 
significant differences in fasting glucose, insulin and HOMAir.  As reported 
previously, the low-fat and medium-fat diet resulted in similar changes in 
anthropometric and metabolic parameters (23, 25). 
 15 
Relationship between the degree of insulin resistance and adipose tissue ATGL and 
HSL protein levels 
Univariate regression analysis, indicated a negative correlation between HOMAir, 
fasting insulin and ATGL or HSL protein levels (all P<0.05), whilst age, gender, body 
composition (waist, FM, FFM) and levels of circulating leptin were not significantly 20 
related to ATGL or HSL protein levels (all P>0.10). Multivariate regression analysis, 
shown in table 2, indicated the same negative correlation between HOMAir (ATGL 
beta-coefficient: -1.33, P=0.045; HSL beta-coefficient: -0.965, P=0.039; see table 2) 
fasting insulin (ATGL beta-coefficient: -1.41, P=0.048; HSL beta-coefficient: -1.07, 
P=0.032; see table 2) and ATGL or HSL protein levels. These data indicate that the 25 
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insulin resistant state rather than fat mass per se causes the decrease in adipose tissue 
ATGL and HSL protein levels. 
To illustrate the impact of insulin resistance on ATGL and HSL protein levels, 
subjects were assigned as insulin sensitive (IS) or insulin resistant (IR) based on 
HOMAir (see Material & Methods, Subjects). Anthropometric and metabolic 5 
characteristics of IS and IR subjects are displayed in table 1. Adipose tissue ATGL 
and HSL protein levels were found to be dramatically reduced in IR compared to IS 
obese subjects. ATGL protein levels were decreased by 72% in IR compared to IS 
obese subjects (IR vs. IS: 2.6±1.3 vs. 9.3±3.6 Adj.Vol.OD, P=0.025; see figure 1B), 
whereas the corresponding figure for HSL was 57% (6.6±2.3 vs. 15.4±3.0 10 
Adj.Vol.OD, P=0.001; see figure 1B). ATGL and HSL protein levels were highly 
correlated (beta-coefficient: 1.05, r=0.568, P=0.0001; see figure 2), indicating that 
ATGL and HSL protein levels might be tightly coregulated in adipose tissue of obese 
subjects.  
As indicated in the methods section, FCV and FCW were determined in a subset of 15 
insulin sensitive (n=19) and insulin resistant (n=20) subjects from the same cohort 
with similar characteristics with respect to HOMAir (1.5±0.1 vs. 4.7±0.5; P<0.01), 
body fat % (42.5±1.1 vs. 42.8±2.0; P=0.742) and waist (108±2 vs. 114±2; P=0.031) 
and similar diet–induced changes. Fat cell volume (FCV) and fat cell weight (FCW) 
were significantly higher (12%; P=0.039) in IR compared with IS subjects and 20 
decreased significantly after weight loss (P<0.01), see table 1. When ATGL and HSL 
protein expression was corrected for mean FCV or FCW the difference between 
groups remained significant (for ATGL, IR vs. IS: 2.6±0.6 vs. 3.9±0.5, P<0.01; for 
HSL, IR vs. IS: 9.2±1.5 vs. 13.4±1.6. P<0.01). 
 25 
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ATGL and HSL mRNA expression in insulin sensitive versus insulin resistant subjects 
Additionally, ATGL and HSL mRNA expression was determined in a subset of 
adipose tissue samples of 26 subjects. In agreement with the protein expression data, 
ATGL and HSL mRNA expression were significantly lower in IR (n=13) compared 
to IS (n=13) obese subjects (P=0.006 and P=0.057, respectively; see figure 1A). Also, 5 
a positive correlation was found for ATGL and HSL mRNA expression (beta-
coefficient: 0.531, r= 0.253, P=0.005), suggesting that the two enzymes belong to a 
common regulatory network with tight transcriptional control. 
 
Effect of weight reduction on adipose tissue ATGL and HSL protein levels 10 
A 10-week hypocaloric diet resulted in a decreased adipose tissue ATGL (before vs. 
after 5.7±1.8 vs. 1.4±0.4 Adj.Vol.OD, P=0.04; see figure 3B) and HSL (before vs. 
after: 10.8±1.9 vs. 5.9±1.3 Adj.Vol.OD, P=0.023; see figure 3B) protein level. When 
ATGL and HSL protein expression was corrected for mean FCV or FCW the 
difference remained significant (for ATGL, before vs. after: 3.2±0.5 vs. 2.1±0.4, 15 
P=0.02; for HSL: before vs. after: 11.1±1.8 vs. 7.5±1.4, P<0.01). Low-fat and 
medium-fat diets resulted in similar changes in ATGL and HSL protein levels. To 
find out the effect of changes in anthropometric and metabolic parameters on ATGL 
and HSL protein levels univariate and multivariate regression analysis was applied 
(see table 3). Univariate regression analysis, indicated a positive correlation between 20 
the decrease in leptin and the decrease in ATGL protein level after weight reduction 
(P<0.05) whilst age, gender, changes in body composition (FM, FFM) and insulin 
were not significantly related to changes in ATGL protein level (all P>0.10). 
Multivariate regression analysis (see table 3) indicated the same positive correlation 
between the decrease in leptin and the decrease in ATGL protein level after weight 25 
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reduction (beta-coefficient: 6.05E-02, P=0.023; see table 3). In addition, univariate 
regression analysis indicated a positive correlation between the decrease in FFM and 
the decrease in HSL protein level after weight reduction (P<0.05) whilst age, gender, 
changes in fat mass, circulating levels of insulin and leptin were not significantly 
related to changes in HSL protein level (all P>0.10). Multivariate regression analysis 5 
(see table 3) indicated the same positive correlation between the decrease in FFM and 
decrease in HSL protein level after weight reduction (beta-coefficient: 0.67, P=0.020; 
see table 3).  
Finally, the correlation between ATGL and HSL protein levels found during habitual 
dietary conditions was also observed after a 10-week hypocaloric diet (beta-10 
coefficient: 0.99, r=0.484, P<0.0001). Also, changes in ATGL and HSL induced by 
weight loss highly correlated to each other (beta-coefficient: 1.01, r=0.503, P=0.004; 
see figure 4). This coordinated variation in ATGL and HSL expression during various 
dietary conditions suggests that the two enzymes share a common regulatory network. 
 15 
ATGL and HSL mRNA expression after the diet 
In line with the protein expression data a 10-week hypocaloric diet significantly 
lowered adipose tissue ATGL (P=0.001) and HSL (P=0.007) mRNA expression, see 
figure 3A. Low-fat and medium-fat diets resulted in similar changes in ATGL and 
HSL mRNA expression. A strong positive correlation was found between ATGL and 20 
HSL mRNA expression after the diet (beta-coefficient: 0.761, r=0.578, P<0.0001). 
The changes in ATGL and HSL mRNA expression induced by weight loss tended to 
correlate positively (P=0.135). 
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Discussion  
 
Our study, for the first time, examined the relationship between adipose tissue ATGL 
and HSL mRNA and protein expression, and whole-body insulin sensitivity in a 
group of obese subjects. The major finding of the present study is that a reduced 5 
ATGL and HSL mRNA and protein expression is associated with insulin resistance 
independent of fat mass. Weight reduction decreased, rather than increased ATGL 
and HSL mRNA and protein expression. When ATGL and HSL protein expression 
was corrected for mean FCV or FCW the differences between groups remained 
significant. In addition, ATGL and HSL mRNA and protein expression seem to be 10 
tightly coregulated in adipose tissue, suggesting that they belong to a common 
regulatory network. 
Our data indicate that the degree of insulin resistance and hyperinsulinemia in obesity 
rather than the increase in fat mass and body fat distribution per se is associated with a 
reduced ATGL and HSL protein and mRNA level.  Since we only studied expression 15 
in abdominal subcutaneous fat we cannot rule out depot-specific differences in ATGL 
and HSL expression. For instance, it has been shown that HSL mRNA expression is 
significantly different in subcutaneous and visceral adipose tissue, a finding that could 
not be confirmed for ATGL mRNA expression (29). There is accumulating evidence 
from in vitro and animals studies that insulin reduces HSL and ATGL expression. It is 20 
documented that insulin downregulates ATGL and HSL mRNA levels in 3T3-L1 
adipocytes in a dose dependent manner (19, 21, 22). More interestingly, ATGL is 
downregulated in a mouse model for insulin resistance by 50% (7). In accordance, our 
data indicate a 72% reduction in adipose tissue ATGL protein levels of insulin 
resistant compared to insulin sensitive obese subjects. Moreover, HSL mRNA levels 25 
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are increased in adipocytes from insulin-deficient streptozotocin-treated rats as 
compared to controls suggesting a negative effect of insulin on HSL expression (20).  
Weight reduction decreased, rather than increased ATGL and HSL protein and 
mRNA expression levels with no effect of diet composition and independent of 
changes in fat mass. This seems consistent with Viguerie et al. reporting a similar 5 
decrease in HSL mRNA for the low-fat and medium-fat diet (25). This 
downregulation of key enzymes for triglyceride breakdown and the increase in 
lipoprotein lipase mRNA level after weight loss (30), potentially enhances lipid 
storage and making further weight loss more difficult. In contrast, Mairal et al. 
showed that adipose tissue ATGL mRNA expression was unchanged and HSL mRNA 10 
expression increased after long-term weight reduction in obese subjects (29). It should 
be mentioned that in this study the second biopsy was taken 2-4 years after surgery. A 
factor explaining the inconsistent findings may be that different conditions are 
compared. In the present study subjects were investigated while still on the energy-
restricted diet (second biopsy taken just at the end of the diet). The negative energy 15 
balance produced by the energy-restricted diet is known to profoundly modify 
adipocyte metabolism, particular the lipolytic pathway, making it impossible to 
differentiate between the chronic effect of weight reduction per se and the acute effect 
of energy restriction. Interestingly, the decrease in leptin correlated positively with the 
decrease in ATGL expression after energy restriction, independent of changes in fat 20 
mass, fat free mass and circulating insulin levels. Flier et al. advocate that this 
decrease in leptin concentration serves as an important signal from fat to the brain that 
the body is starving (31). In addition, it has been proposed that an important function 
of leptin is to confine storage of triglycerides to adipocytes (i.e. to affect adipose 
 18 
tissue lipolysis) and to prevent triglyceride storage in non-adipocytes (e.g. myocytes), 
protecting them from lipotoxicity (32).  
In obese subjects we observed no strict relationship between fat mass and ATGL or 
HSL expression, and fat cell size per se was not important for our findings. When the 
obese state has already developed insulin resistance and hyperinsulinemia seem to be 5 
the major determinants for ATGL and HSL protein expression. This seems in line 
with the observation of a negative correlation between fasting insulin and in vivo fatty 
acid outflow per unit of adipose tissue in insulin resistant conditions (18), suggesting 
that a reduced expression of ATGL and HSL may be a secondary phenomenon to 
insulin resistance. It can be speculated that hyperinsulinemia may downregulate 10 
adipose tissue lipolysis and thereby prevent worsening of the insulin resistant state 
(33, 34). In the present study weight loss had no significant effect on insulin 
sensitivity. To fully elucidate the effect of insulin resistance on ATGL and HSL 
expression an intervention should be performed which significantly improves insulin 
sensitivity (e.g. exercise training or treatment with a PPAR- {gamma} agonist). It has 15 
been shown that ATGL is subject to transcriptional control by PPAR- {gamma} 
mediated signals (22). In addition, Festuccia et al. recently showed that treatment of 
mice with the PPAR- {gamma} agonist rosiglitazone significantly increased ATGL 
and HSL mRNA expression (35), indicating that an improved insulin sensitivity 
increases adipose tissue ATGL and HSL expression. Finally, we cannot rule out that a 20 
decreased ATGL and HSL expression is a primary defect in obesity. Interestingly, 
ATGL-deficient mice have an increased fat storage in adipose and non-adipose tissues 
(36). Further, studies in first-degree relatives of obese subjects have demonstrated an 
impaired lipolytic function of adipocytes, suggesting that also primary adipocyte 
lipolysis defects are present in obesity (13). Expression of HSL is markedly decreased 25 
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in subcutaneous adipocytes and differentiated preadipocytes from obese subjects, 
suggesting a decreased HSL expression to be a primary defect in obesity {Large, 1999 
#244; Lofgren, 2002 #263; Viguerie, 2005 #259; Reynisdottir, 1994 #234}. Also 
several studies suggest that genetic variation in the HSL and ATGL gene are 
associated with obesity and type 2 diabetes mellitus (37, 38). Further research is 5 
needed to elucidate the exact order of events. 
The coregulation between ATGL and HSL protein levels or mRNA expression (39) 
during different dietary conditions suggests that the two enzymes belong to a common 
regulatory network with tight transcriptional control. A recent study indicated that 
HSL is the major lipase catalyzing the rate-limiting step in stimulated lipolysis, 10 
whereas ATGL participates in basal lipolysis (39). Insufficient time has passed since 
the discovery of ATGL to understand the nature of its regulation. However from the 
limited data available, it appears that in comparison to HSL, ATGL is not a direct 
target for protein kinase A (PKA)-mediated phosphorylation and is localized on the 
lipid droplet in the basal and hormone-stimulated state of the cell (9). These 15 
observations suggest that ATGL is not activated by phosphorylation and translocation 
to the lipid droplet as demonstrated for HSL. Instead, an activator protein regulates 
ATGL activity: CGI-58 (comparative gene identification 58) (40) (41). It will be 
important to establish whether the decreased HSL and ATGL protein and mRNA 
expression observed in insulin resistant subjects is also accompanied by a decreased 20 
activity of both enzymes. 
In conclusion, ATGL and HSL expression are decreased in the obese insulin resistant 
state. When the obese state has already developed insulin resistance or 
hyperinsulinemia seem to be the major determinant of ATGL and HSL protein 
expression independent of fat mass. On the other hand, there are also indications that 25 
 20 
a reduced ATGL and HSL protein expression is a primary defect in obesity. Weight 
reduction decreased ATGL and HSL expression, independent of circulating insulin 
and FM, indicating that also other factors (e.g. leptin) relate to ATGL and HSL 
protein expression in obese subjects. 
5 
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